Volume 55, Issue 6, Pages (June 1999)

Slides:



Advertisements
Similar presentations
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Advertisements

Acid-base profile in patients on PD
Home care assistance and the utilization of peritoneal dialysis
A skeptical view of assisted home peritoneal dialysis
Volume 59, Issue 2, Pages (February 2001)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Volume 66, Issue 6, Pages (December 2004)
Linear and logistic regression analysis
Use of hemodialysis and hemoperfusion in poisoned patients
Acid-base profile in patients on PD
End-stage renal disease in developing countries
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis  James F. Medcalf, Kevin P.G.
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Volume 64, Pages S3-S12 (December 2003)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
The risk of hospitalization and modality failure with home dialysis
Volume 75, Issue 11, Pages (June 2009)
Christopher D. Miller, Michelle L. Robbin, Michael Allon 
Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real?  S. Andrulli, S. Di Filippo, F. Locatelli 
Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie 
Volume 73, Issue 4, Pages (February 2008)
Volume 56, Issue 2, Pages (August 1999)
How to interpret the eGFR in patients with small body surface area
The online measurement of hemodialysis dose (Kt): Clinical outcome as a function of body surface area  Edmund G. Lowrie, Zhensheng Li, Norma Ofsthun,
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 57, Issue 6, Pages (June 2000)
Late referral and modality choice in end-stage renal disease
Volume 73, Pages S5-S17 (April 2008)
Body size and outcomes on peritoneal dialysis in the United States
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Blood pressure targets in hemodialysis patients
Jeffrey Perl, MD, FRCP(C), Christopher T. Chan, MD, FRCP(C) 
Volume 54, Issue 2, Pages (August 1998)
Peritoneal dialysis adequacy and risk of death
Volume 69, Issue 12, Pages (June 2006)
Alternate-day dialysis may be needed for hemodialysis patients
Volume 56, Issue 5, Pages (November 1999)
Nephrology Crossword: Peritoneal Dialysis
Volume 55, Issue 4, Pages (April 1999)
Profiling of peritoneal ultrafiltration
Urea kinetic analysis of automated peritoneal dialysis allows calculation of a CAPD- equivalent Kt/Vurea  Scott J. Schurman, Lawrence R. Shoemaker, Bradley.
Volume 73, Pages S72-S75 (April 2008)
Volume 65, Issue 4, Pages (April 2004)
Volume 59, Issue 6, Pages (June 2001)
A skeptical view of assisted home peritoneal dialysis
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Dialysis dose and gender: A different hypothesis
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
Volume 70, Pages S84-S90 (November 2006)
Volume 53, Issue 5, Pages (May 1998)
Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial  D. Demetriou, A. Habicht, M. Schillinger,
Volume 80, Issue 10, Pages (November 2011)
Changing hemodialysis thresholds for optimal survival
Bradley A. Warady, Mwaffek Bashir, Lynn A. Donaldson 
American Journal of Kidney Diseases
Volume 60, Issue 5, Pages (November 2001)
Volume 86, Issue 2, Pages (August 2014)
Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton 
Volume 59, Issue 2, Pages (February 2001)
Volume 61, Issue 2, Pages (February 2002)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 87, Issue 6, Pages (June 2015)
Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary 
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Letter from W. Lornoy; I. Becaus; J.M. Billiouw and L. Sierens
Presentation transcript:

Volume 55, Issue 6, Pages 2493-2501 (June 1999) Peritoneal dialysis adequacy: A model to assess feasibility with various modalities  Jose A. Diaz-Buxo, Frank A. Gotch, Tom I. Folden, Shelden Rosenblum, James Zazra, Nancy Lew, Terri L. Crawford, Brenda Youngblood, Angie Pesich, J. Michael Lazarus  Kidney International  Volume 55, Issue 6, Pages 2493-2501 (June 1999) DOI: 10.1046/j.1523-1755.1999.00472.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Distribution of body surface area (BSA) for (A) hemodialysis, (B) peritoneal dialysis, and (C) a combined group of dialysis patients. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Relationship between weekly Kpt/Vurea and volume of distribution of urea (Vsa) according to four different peritoneal dialysis prescriptions and peritoneal transport rates. Symbols are: (–) PD Plus-15; (•) PD Plus-12; (+) CAPD-10; (•) CAPD-8. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 Relationship between weekly CCr and peritoneal transport rates for four different prescriptions. The figures in parenthesis denote the number of patients studied. A description of the dialysis prescriptions is in the text. Symbols are: (•) CAPD-8; (•) CAPD-10; (▾) PD Plus-12; (▿) PD Plus-15. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 4 Predicted weekly Kpt/V for a male patient with a BSA=1.73m2 and a Vsa=35.6 liters according to peritoneal transport rate and prescription. The values over each bar denote Kpt/V for the specific PTR and prescription. Symbols are: (□) low; (▤) low-average; (▥) high-average; (▪) high. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 5 Predicted maximum body surface area (BSA) for males and females undergoing different prescriptions according to peritoneal transport rate in order to achieve a Kpt/V of 2.1 or more. Values above the bars denote the BSA for the specific PTR, prescription, and gender. Abbreviations are: L, low; LA, low-average; HA, high-average; H, high; M, male; and F, female. Symbols are: (▨) L-M; () L-F; (▤) LA-M; () LA-F; (▥) HA-M; () HA-F; (□) H-M; (▪) H-F. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 6 Predicted proportion of male patients capable of achieving a weekly Kpt/V of 2.1 or more according to modality of therapy and peritoneal transport rates. Values above the bars denote the percentage of patients achieving Kpt/V for that specific PTR group and prescription. The total percentage refers to the total proportion of male patients predicted to attain a Kpt/V=2.1 with that particular prescription. Symbols are: (□) low; (▤) low-average; (▥) high-average; (▪) high. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 7 Predicted proportion of female patients capable of achieving a weekly Kpt/V of 2.1 or more according to modality of therapy and peritoneal transport rates. Symbols are: (□) low; (▤) low-average; (▥) high-average; (▪) high. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 8 Predicted proportion of all patients capable of achieving a weekly Kpt/V of 2.1 or more according to modality of therapy and peritoneal transport rates. Symbols are: (□) low; (▤) low-average; (▥) high-average; (▪) high. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 9 Predicted proportion of patients capable of achieving a weekly CCr of 60 liter/1.73m2 or more according to modality of therapy and peritoneal transport rates. Symbols are: (□) low; (▤) low-average; (▥) high-average; (▪) high. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 10 Predicted maximum body surface area (BSA) for patients undergoing different modalities according to peritoneal transport rate in order to achieve a CCr of 60 liter/1.73m2 or more. Symbols are: (□) low; (▤) low-average; (▥) high-average; (▪) high. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 11 Relationship between total daily volume of dialysis solution used and degree of adequacy achieved according to the two adequacy criteria used: (▪) weekly Kpt/Vurea=2.1 and (□) CCr=60 liter/1.73m2. Solid lines without symbols represent linear regressions. Kidney International 1999 55, 2493-2501DOI: (10.1046/j.1523-1755.1999.00472.x) Copyright © 1999 International Society of Nephrology Terms and Conditions